Advertisements


Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta

Zacks.....»»

Category: topSource: redinewsNov 19th, 2018

Novartis (NVS) Gets FDA Nod for Label Expansion of Promacta

Novartis (NVS) obtains FDA approval for the label expansion of Promacta. The CHMP also issues a positive opinion for the label expansion of Kisqali. Novartis AG NVS announced that the FDA has expanded the label of Promacta (eltrombopag) .....»»

Category: smallbizSource: nytNov 19th, 2018

Novartis Gets Positive CHMP Opinion for Drugs, Biosimilar

Novartis (NVS) gets positive CHMP opinion for a label expansion of Gilenya, gene therapy, and a biosimilar of Neulasta. Novartis AG NVS announced that the Committee for Medi.....»»

Category: personnelSource: nytSep 24th, 2018

Novartis" (NVS) Kisqali Gets FDA Nod for Label Expansion

Novartis' (NVS) breast cancer drug, Kisqali, gets FDA appro.....»»

Category: worldSource: nytJul 19th, 2018

Bristol-Myers" Sprycel Gets European Nod for Label Expansion

Zacks.....»»

Category: topSource: redinewsFeb 13th, 2019

Seattle Genetics" Adcetris Gets EC Nod for Label Expansion

Zacks.....»»

Category: topSource: redinewsFeb 12th, 2019

Seattle Genetics label expansion likely to drive Q4 beat, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 29th, 2019

Clovis" Rubraca Gets Nod as Maintenance Therapy in Europe

Clovis Oncology (CLVS) announces approval of label expansion for Rubraca to include maintenance treatment of ovarian cancer pati.....»»

Category: personnelSource: nytJan 28th, 2019

Pacira"s Study on Exparel Label Expansion Meets Endpoints

Zacks.....»»

Category: topSource: redinewsJan 18th, 2019

Pacira"s Study on Exparel Label Expansion Meets Endpoints

Pacira's (PCRX) phase IV study of its lead drug Exparel in patients underg.....»»

Category: personnelSource: nytJan 17th, 2019

Roche"s sBLA for Tecentriq-Abraxane Combo Accepted by FDA

Roche's (RHHBY) sBLA for the label expansion of Tecentriq in combination with Abraxane for the initial treat.....»»

Category: smallbizSource: nytJan 17th, 2019

Regeneron (REGN) Sails Steady on Label Expansion of Drugs

Zacks.....»»

Category: topSource: redinewsJan 16th, 2019

Regeneron (REGN) Sails Steady on Label Expansion of Drugs

Regeneron's (REGN) performance has been steady in the past six months even as the overall industry d.....»»

Category: dealsSource: nytJan 16th, 2019

Bristol-Myers" (BMY) Sprycel Gets FDA Nod for Label Expansion

Zacks.....»»

Category: topSource: redinewsJan 3rd, 2019

Alexion"s (ALXN) Soliris Drives Growth Amid Pricing Pressure

Alexion (ALXN) drives growth on consistent demand for lead drug, Soliris. The label expansion of the drug should further propel sales and combat pricing pressu.....»»

Category: worldSource: nytDec 27th, 2018

AMAG Up Nearly 10% in a Year on Label Expansion, Acquisitions

Zacks.....»»

Category: topSource: redinewsDec 27th, 2018

Bristol-Myers" Label Expansion of Sprycel Gets CHMP Nod

Bristol-Myers (BMY) gets positive opinion from the CHMP on the label expansion of Sprycel. The company also collaborates with other institutions for d.....»»

Category: smallbizSource: nytDec 18th, 2018

Roche"s Tecentriq Gets FDA Approval for First-Line NSCLC

Roche's (RHHBY) Tecentriq in combination with Avastin obtains FDA nod for the initial treatment of NSCLC. Roche RHHBY announced that the FDA has approved a label expansion of its imm.....»»

Category: smallbizSource: nytDec 10th, 2018

J&J"s Blood Cancer Drugs Succeed in Label Expansion Studies

Zacks.....»»

Category: topSource: redinewsDec 5th, 2018

Piper gets positive feedback on Seattle Genetics label expansion

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 27th, 2018

AMAG"s Label Expansion of Lead Products Raises Share Price

Sha.....»»

Category: futuresSource: nasdaqNov 27th, 2018